Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a huge worldwide healthcare burden. The incidence of non-viral causes of hepatocellular carcinoma, such as non-alcoholic steatohepatitis (NASH), is rising. The introduction of immune checkpoint inhibitors (ICI) has led to a paradigm shift in the syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Landon L., Chan, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946632/
https://www.ncbi.nlm.nih.gov/pubmed/35326677
http://dx.doi.org/10.3390/cancers14061526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946632/
https://www.ncbi.nlm.nih.gov/pubmed/35326677
http://dx.doi.org/10.3390/cancers14061526

Ejemplares similares